APP and Alzheimer disease: Through literature review, it was found that there is no systematic report on exploring early diagnostic imaging biomarkers for AD through the combination of sMRI, rs-fMRI, and 1H-MRS multimodal MRI technology based on APP/PS1 transgenic mice.